Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Hyperhidrosis can affect anyone, regardless of gender or age
Key findings across Phase II and III trials: Women receiving PT-141 showed statistically significant increases in satisfying sexual events per month compared to placebo Reduction in sexual distress scores was observed across multiple validated instruments Effects were noted within the first treatment cycle and maintained across the 12-week study period Response was not limited to any one demographic subgroup efficacy was consistent across age ranges within the premenopausal population Research Context for Male Sexual Dysfunction While PT-141s FDA approval is specifically for HSDD in women, substantial preclinical and Phase II research has examined its effects in men particularly in cases where psychological or neurological factors contribute to sexual dysfunction that vascular agents alone cannot address
The results of these subgroup analyses are presented in Table 4, Table 5, Table 6, and Table 7, respectively, illustrating the stratification based on patient gender, age, indications, and treatment duration
It raises resting energy expenditure, so the body burns more calories even at rest
US$ 20.61
US$ 23.34
US$ 28.12
US$ 22.72
US$ 23.14
US$ 25.19
US$ 29.43
US$ 23.96
US$ 21.69
US$ 24.33
US$ 20.63
US$ 24.58
